University, Diss., 2005--Köln.

Adaptor-protein-4-deficiency (AP-4-deficiency) is an autosomal-recessive childhood- onset form of complicated hereditary spastic paraplegia (HSP) caused by bi-allelic loss- of-function mutations in one of the four subunits of the AP-4-complex. These four conditions are named SPG47 (AP4B1, OMIM #614066), SPG50 (AP4M1, OMIM #612936), SPG51 (AP4E1, OMIM #613744) and SPG52 (AP4S1, OMIM #614067), respectively and all present with global developmental delay, progressive spasticity and seizures. Imaging features include a thinning of the corpus callosum, ventriculomegaly and white matter changes. AP-4 is a highly conserved heterotetrameric complex, which is responsible for polarized sorting of transmembrane cargo including the autophagy- related protein 9 A (ATG9A). Loss of any of the four subunits leads to an instable complex and defective sorting of AP-4-cargo. ATG9A is implicated in autophagosome formation and neurite outgrowth. It is missorted in AP-4-deficient cells and CNS-specific knockout of Atg9a in mice results in a phenotype reminiscent of AP-4-deficiency. However, the AP-4-related cellular phenotypes including ATG9A missorting have not been investigated in human neurons. Thus, the aim of this study is to provide the first human induced pluripotent stem cell- derived (iPSC) cortical neuron model of AP-4-deficiency to explore AP-4-related phenotypes in preparation for a high-content screening. Under the hypothesis that AP-4- deficiency leads to ATG9A missorting, elevated ATG9A levels, impaired autophagy and neurite outgrowth in human iPSC-derived cortical neurons, in vitro biochemical and imaging assays including automated high-content imaging and analysis were applied. First, these phenotypes were investigated in fibroblasts from three patients with compound heterozygous mutations in the AP4B1 gene and their sex-matched parental controls. The same cell lines were used to generate iPSCs and differentiate them into human excitatory cortical neurons. This work shows that ATG9A is accumulating in the trans-Golgi-network in AP-4- deficient human fibroblasts and that ATG9A levels are increased compared to parental controls and wild type cells suggesting a compensatory mechanism. Protein levels of the AP4E1-subunit were used as a surrogate marker for the AP-4-complex and were decreased in AP-4-deficient fibroblasts with co-immunoprecipitation confirming the instability of the complex. Lentiviral re-expression of the AP4B1-subunit rescues this corroborating the fact that a stable AP-4-complex is needed for ATG9A trafficking. Surprisingly, autophagic flux was present in AP-4-deficient fibroblasts under nutrient- rich and starvation conditions. These phenotypic markers were evaluated in iPSC-derived cortical neurons and here, a robust accumulation of ATG9A in the juxtanuclear area was seen together with elevated ATG9A protein levels. Strikingly, assessment of autophagy markers under nutrient-rich conditions showed alterations in AP-4-deficient iPSC- derived cortical neurons indicating dysfunctional autophagosome formation. These findings point towards a neuron-specific impairment of autophagy and need further investigation. Adding to the range of AP-4-related phenotypes, neurite outgrowth and branching are impaired in AP-4-deficient iPSC-derived cortical neurons as early as 24h after plating and together with recent studies point towards a distinct role of ATG9A in neurodevelopment independent of autophagy. Together, this work provides the first patient-derived neuron model of AP-4-deficiency and shows that ATG9A is sorted in an AP-4-dependent manner. It establishes ATG9A- related phenotypes and impaired neurite outgrowth as robust markers for a high-content screening. This disease model holds the promise of providing a platform to further study AP-4-deficiency and to search for novel therapeutic targets. / Die Adaptor-Protein-4-Defizienz (AP-4-Defizienz) ist eine autosomal-rezessiv vererbte, komplizierte Form hereditären spastischen Paraplegien (HSPs), welche durch biallelische Mutationen in einer der vier Untereinheiten des AP-4-Gens verursacht wird. Die vier resultierenden Erkrankungen werden SPG47 (AP4B1, OMIM #614066), SPG50 (AP4M1, OMIM #612936), SPG51 (AP4E1, OMIM #613744) und SPG52 (AP4S1, OMIM #614067) genannt und präsentieren sich mit globaler Entwicklungsverzögerung im frühen Säuglingsalter, progressiver Spastik sowie Krampfanfällen. Radiologische Zeichen beinhalten ein verschmälertes Corpus callosum, Ventrikulomegalie und Veränderungen der weißen Substanz. AP-4 ist ein hoch konservierter, heterotetramerer Proteinkomplex, welcher für die polarisierte Verteilung von Transmembranproteinen einschließlich des „autophagy-related protein 9 A“ (ATG9A) zuständig ist. Eine „lossof- function“ Mutation in einer der vier Untereinheiten führt zur Instabilität des gesamten Komplexes und zur Beeinträchtigung des AP-4-abhängigen Proteintransportes. ATG9A ist notwendig für die Bildung von Autophagosomen und das Neuritenwachstum. In AP- 4-defizienten Zellen ist der ATG9A-Transport beeinträchtigt und ein ZNS-spezifischer Knockout von ATG9A erzeugt in Mäusen einen Phenotyp, der große Überschneidungen mit dem der AP-4-Defizienz aufweist. Bisher sind diese AP-4-abhängigen zellulären Phenotypen nicht in humanen Neuronen untersucht worden. Daher ist die Entwicklung des ersten humanen aus induzierten pluripotenten Stammzellen (iPSC) abgeleiteten kortikalen Neuronenmodells der AP-4-Defizienz und die Identifikation AP-4-abhängiger Phenotypen für die Anwendung in einem Hochdurchsatzscreening das Ziel dieser Arbeit. Unter der Hypothese, dass AP-4- Defizienz in humanen iPSC-abgeleiteten kortikalen Neuronen zu ATG9A Fehltransport, erhöhtem ATG9A Protein, beeinträchtigter Autophagie und vermindertem Neuritenwachstum führt, wurden biochemische und automatisierte, Mikroskopie-basierte in vitro Assays entwickelt. Zunächst wurden primäre humane Fibroblasten von Patienten mit compound-heterozygoten Mutationen im AB4B1-Gen und geschlechtsangepasste, elterliche Kontrollzellen auf die genannten Phenotypen hin untersucht. Dieselben Zelllinien wurden anschließend für die Generierung von iPSCs und die Differenzierung in exzitatorische kortikale Neurone verwendet. 90 Diese Arbeit zeigt, dass ATG9A in AP-4-defizienten Fibroblasten im Bereich des Trans- Golgi-Netzwerkes akkumuliert und das ATG9A Proteinlevel erhöht sind, was auf eine kompensatorische Hochregulierung hindeutet. Die Proteinlevel der AP4E1-Untereinheit wurden als Surrogatparameter für einen stabilen AP-4-Komplex genutzt und waren in AP-4-defizienten Fibroblasten vermindert. In der Co-Immunpräzipitation konnte eine Instabilität des AP-4-Komplexes bestätigt werden. Die lentivirale Reexpression der AB4B1-Untereinheit führte zu einer Wiederherstellung des Wildtyp-Phänotyps und zeigt damit, dass ein stabiler AP-4-Komplex für die korrekte Verteilung von ATG9A notwendig ist. Trotz der bekannten Beteiligung von ATG9A an der Bildung von Autophagosomen, zeigte sich eine intakte Autophagosomenbildung und Degradation in AP-4-defizienten Fibroblasten. Die beschriebenen phänotypischen Marker wurden in iPSC-abgeleiteten kortikalen Neuronen evaluiert und auch hier konnten eine juxtanukleäre Akkumulation von ATG9A sowie erhöhte ATG9A Proteinlevel demonstriert werden. Im Gegensatz zu den Fibroblasten, zeigten AP-4-defiziente iPSCabgeleitete kortikale Neurone bereits unter nährstoffreichen Bedingungen eine Konstellation von Autophagiemarkern, die auf eine gestörte Autophagosomenbildung und damit auf eine Neuronen-spezifische Störung von Autophagie hindeuten und der weiteren Untersuchung bedürfen. Zusätzlich fand sich bei AP-4-defizienten kortikalen Neuronen bereits in den ersten 24 Stunden im Inkubator eine Störung des Neuritenwachstums und der -verzweigung, welche in Zusammenschau mit kürzlich erschienenen Arbeiten auf eine zusätzliche Autophagie-unabhängige Funktion von ATG9A hinweisen. Diese Arbeit stellt zusammenfassend die Entwicklung des ersten Patienten-abgeleiteten Neuronenmodells der AP-4-Defizienz dar und zeigt das ATG9A in einer AP-4-abhänigen Weise in der Zelle verteilt wird. Weiterhin etabliert diese Arbeit ATG9A-abhängige zelluläre Phänotypen und gestörtes Neuritenwachstum als robuste phänotypische Marker für ein High-Content Screening. Dieses zelluläre Krankheitsmodell trägt das Potential als Plattform für weitere Studien der AP-4-Defizienz zu dienen und damit neue therapeutische Möglichkeiten aufzudecken.

München, Techn. Universiẗat, Diss., 2007.

Die Bedeutung der β-Arrestine als multifunktionelle Adapterproteine GPCR-vermittelter Signaltransduktion hat in den letzten Jahren immer mehr zugenommen. In der vorliegenden Arbeit lag der Schwerpunkt auf der Untersuchung der molekularen Basis und der Ligandenabhängigkeit sowohl der β-Arrestin/Rezeptor-Interaktion als auch β-Arrestin- (un-)abhängiger Signaltransduktionsmechanismen. Im ersten Teil wurde der Einfluß potentieller Phosphorylierungsstellen im C-Terminus des β2AR bzw. im C-Terminus und der TM3 des P2Y1R auf die agonisteninduzierte β-Arrestin/Rezeptor-Interaktion, Internalisierung und Desensibilisierung untersucht. Durch Mutationsanalysen konnten Ser 352/Thr 358 im distalen C-Terminus des P2Y1R als Schlüsselstellen der β-Arrestin-Translokation und Internalisierung identifiziert werden, während ein oder mehrere Phosphorylierungsstellen im proximalen P2Y1R C-Terminus die molekulare Grundlage der Rezeptordesensibilisierung darstellen. Darüber hinaus machte die Anwendung verschiedener PKC- oder CaMK-Inhibitoren sowie der Einsatz des PKC-Aktivators PMA deutlich, dass die P2Y1R-Desensibilisierung und β-Arrestin-Translokation durch unterschiedliche Kinasen kontrolliert werden. Zudem konnte mit Hilfe der FRET-Technik gezeigt werden, dass die Phosphorylierungsstellen zwischen den Positionen 355 und 364 im proximalen β2AR C-Terminus essentielle Bereiche der β-Arrestin-Translokation darstellen. Im zweiten Teil der vorliegenden Arbeit wurden Agonisten am β2-adrenergen Rezeptor bzw. dem P2Y2R auf ihre Fähigkeit hin untersucht verschiedene mit dem jeweiligen Rezeptor verknüpfte G-Protein- bzw. β-Arrestin-Funktionen in unterschiedlichem Ausmaß zu aktivieren („biased agonism“). Da eine solche ligandenselektive Aktivierung rezeptorvermittelter Signalwege bis dato nur mit synthetischen Liganden detailliert untersucht wurde, galt das besondere Interesse der Analyse der durch die endogenen Substanzen induzierten Signalmuster. Die Betrachtung der Noradrenalin- bzw. Adrenalin-induzierten β-Arrestin/Rezeptor-Interaktion, β-Arrestin2-Translokation, Rezeptorinternalisierung, G-Protein-Aktivierung sowie cAMP-Produktion am β2AR machte deutlich, dass es sich beim Phänomen des „biased agonism“ um einen endogenen Mechanismus handelt. Darüber hinaus konnte gezeigt werden, dass auch zur Tokolyse eingesetzte β2AR-Agonisten spezifische Signalmuster induzieren. Die Beobachtung, dass UTP und ATP sowohl unterschiedliche β-Arrestin1/2-Translokationsals auch ERK-Aktivierungsmuster am P2Y2R induzieren bestärkte das Konzept des „biased agonism“ als endogenes Phänomen. Das ligandenabhängige β-Arrestin-Translokationsverhalten des P2Y2R ließ zudem die agonistenbedingte Zuteilung des Rezeptors zu den „Klasse A“ oder „Klasse B“ Rezeptoren zu. Die detaillierte Untersuchung agonisteninduzierter Rezeptor/Effektor-Interaktionen und Signalmuster dürfte helfen die Anwendung klinisch relevanter Substanzen zu optimieren. / In recent years, the significance of β-arrestins as multifunctional adapter proteins of GPCR mediated signal transduction has steadily been increasing. In this thesis the main focus is to research the molecular basis and the ligand dependence of the β-arrestin recruitment as well as β-arrestin-(in-)dependent signal transduction mechanisms. In the first part, the influence of potential phosphorylation sites in the C-terminus of the β2AR or the C-terminus and the TM3 of the P2Y1R, respectively, on the agonist-induced β-arrestin2/receptor-interaction, receptor internalization and desensitization was examined. Using mutation analysis, Ser 352 and Thr 358 were identified as key points of the β-arrestin2 translocation and receptor internalization in the distal C-terminus of the P2Y1R. In contrast, one or more phosphorylation sites in the proximal P2Y1R C-terminus represent the molecular basis of receptor desensitization. In addition, the use of different PKC- or CaMK inhibitors and the application of the PKC activator PMA made it clear that the P2Y1R desensitization and β-arrestin translocation are controlled by different kinases. Using the FRET technique we were able to show that the phosphorylation sites between position 355 and 364 in the proximal C-terminus of the β2AR represent essential areas of the β-arrestin2 translocation. In the second part of the study at hand, agonists of the β2AR or the P2Y2R were examined with respect to their ability to activate distinct receptor associated G-protein or β-arrestin functions to varying degrees (“biased agonism”). Since this kind of ligandselective activation of receptor-mediated signaling pathways has only been studied in detail with synthetic ligands to this day, special interest in the analysis of the signaling pattern induced by the endogenous substances was taken. The analysis of norepinephrine- or epinephrine-induced β-arrestin/receptor interaction, β-arrestin translocation, receptor internalization, G-protein activation and cAMP production at the β2AR made clear that “biased agonism” is an endogenous phenomenon. Moreover, it has also been shown that β2AR agonists used for tocolysis induced a specific signaling pattern. The observation that UTP and ATP both induce different β-arrestin translocation as well as ERK activation patterns at the P2Y2R confirmed the concept of “biased agonism” as an endogenous phenomenon. The ligand dependent β-arrestin behavior of the P2Y2R also allowed the allocation of the receptor to the “class A” or “class B” receptors depending on the agonist used for stimulation. The detailed testing of agonist induced receptor/effector interactions and signaling pattern could help to optimize the application of clinically relevant substances.

Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) are exploited by human-specific pathogens to anchor themselves to or invade host cells. Interestingly, human granulocytes express a specific isoform, CEACAM3, that can direct efficient, opsonin-independent phagocytosis of CEACAM-binding Neisseria, Moraxella and Haemophilus species. As opsonin-independent phagocytosis of CEACAM-binding Neisseria depends on Src-family protein tyrosine kinase (PTK) phosphorylation of the CEACAM3 cytoplasmic domain, we hypothesized that an SH2-containing protein might be involved in CEACAM3-initiated, phagocytosis-promoting signals. Accordingly, we screened glutathione-S-transferase (GST) fusion proteins containing SH2 domains derived from a panel of signaling and adapter molecules for their ability to associate with CEACAM3. In vitro pull-down assays demonstrated that the SH2 domain of the adapter molecule Nck (GST-Nck SH2), but not other SH2 domains such as the Grb2 SH2 domain, interact with CEACAM3 in a phosphotyrosine-dependent manner. Either deletion of the cytoplasmic tail of CEACAM3, or point-mutation of a critical arginine residue in the SH2 domain of Nck (GST-NckSH2R308K) that disrupts phosphotyrosine binding, both abolished CEACAM3-Nck-SH2 interaction. Upon infection of human cells with CEACAM-binding Neisseria, full-length Nck comprising an SH2 and three SH3 domains co-localized with tyrosine phosphorylated CEACAM3 and associated bacteria as analyzed by immunofluorescence staining and confocal microscopy. In addition, Nck could be detected in CEACAM3 immunoprecipitates confirming the interaction in vivo. Importantly, overexpression of a GFP-fusion protein of the isolated Nck SH2 domain (GFP-Nck-SH2), but not GFP or GFP-Nck SH2 R308K reduced CEACAM3-mediated phagocytosis of CEACAM-binding Neisseria suggesting that the adaptor molecule Nck plays an important role in CEACAM3-initiated signaling leading to internalization and elimination of human-specific pathogens.

Vesicular traffic along the biosynthetic and endocytic pathways is essential for homeostasis of eukaryotic cells. However, it raised the question of how the proteins characteristic for each compartment are transported to their destination (Bonifacino and Glick, 2004). This study is especially focusing on the connection between the Golgi apparatus and the endosomal compartment, mediated by two parallel trafficking pathways regulated by the clathrin adaptors AP-1A and AP-3 (Owen et al., 2004). Typical cargo molecules sorted along the AP-1A regulated pathway are mannose 6-phosphate receptors (MPRs) (Ghosh et al., 2003) or the gpI envelop glycoprotein of the Vesicular Zoster virus (Alconada et al., 1996), while sorting of lysosomal membrane proteins like Lamp-1 and LimpII is AP-3 regulated (Eskelinen et al., 2003). To study how AP-1A and AP-3 coats are stabilized on membranes and to identify the protein networks involved, a liposome based in vitro assay that recapitulates the fidelity of protein sorting in vivo was developed and combined with proteomic screens. Therefore, liposomes carrying cytoplasmic domains of gpI or Lamp-1/LimpII were used as affinity matrix to recruit selectively AP-1A or AP-3 and associated protein machineries. The coated liposomes were then analyzed by mass spectrometry. Using the in vitro recruitment assay, it was possible to demonstrate that efficient and selective recruitment of AP-1A and AP-3 coats depends on the presence of several low affinity binding sites on membranes. Thus, AP-1A and AP-3 recognize their target membranes by activated Arf1 GTPases, organelle specific phosphoinositides, PI-4P and PI-3P respectively, and distinct cargo molecules carrying intact signals in their cytoplasmic domains. The implication of PI-3P in AP-3 recruitment was further supported by in vivo experiments. During the biochemical characterization of the assay, several lines of evidence indicated that cargo tails containing intact sorting signals stabilize not only AP-1A and AP-3 coats on membranes but also influence the membrane recruitment of Arf1. It is possible that cargo molecules indirectly drive an Arf1 amplification loop, thereby ensuring efficient AP coat assembly. The proteomic screens identified protein networks of ≈40 proteins selectively recruited on AP-1A coated structures. The most appealing result of the analysis was the presence of two additional protein machineries, one involved in actin nucleation the other involved membrane fusion. More precisely, the AP-1A analysis identified the selective recruitment of the AP-1A subunits and interacting molecules (clathrin, g-synergin), Arf1 and Arf1 effectors (Big2, Git1), Rac1 including Rac1 effectors (b-PIX, RhoGEF7) and a Rac1 dependent actin nucleation machinery (Wave/Scar complex, Arp2/3 complex, associated effectors) as well as members of a Rab machinery (Rab11, Rab14). This finding was further supported by in vivo colocalization studies of the AP-1A cargo CI-MPR with CYFIP2, a protein of the Wave/Scar complex, and the localization of Big2 and Git1 on Rab11 positive membranes (Matafora et al., 2001; Shin et al., 2004). The biochemical characterization revealed that the stabilization of AP-1A coats, most probably driven by cargo molecules that stabilize AP-1A and Arf1 on membranes, leads as well to the stabilization of the two other machineries. Thus, the results support the notion that cargo sorting, vesicular movement and membrane fusion are coordinated during early steps of vesicular traffic. In analogy, the proteomic screens on AP-3 coated structures identified as well ≈40 selectively recruited proteins, which constituted a similar supramolecular network of protein machineries involved in coat formation, action nucleation and membrane fusion via Rab proteins. Thus, beside the AP-3 coat including the AP-3 subunits, Arf1 and Arf effectors (Big1, ARAP1, AGAP1), members of the septin family involved in actin rearrangements and most of the already described effectors of Rab5 microdomains (EEA1, Rabaptin-5, Rabex-5, Vps45) involved in early endosomal dynamics were selectively recruited together with Rab5 and Rab7. Thus, the proteomic analysis of AP-1A and AP-3 coated structures suggest that both AP coats use similar principles - coats, actin nucleation devices and Rab fusion machineries - to assemble supramolecular structures needed for membrane traffic. Although we do not have the ultimate proves yet, it seems as AP-1A and AP-3 use different members of subcomplexes, hence different GTPase effectors, different actin nucleation machineries and different Rab GTPases, to regulate their specific transport pathways and to link the different protein machineries. The proteomic analysis revealed for example that they probably use different Arf and Rho GTPase effectors to link the coat with actin nucleation. However, this has to be proven experimentally. In order to understand the networks of protein interactions, bioinformatic tools were used as a first approach. Even though some clues about the overall organization of the supramolecular protein complexes were provided, the direct links to the Rab machinery are still elusive. Maybe the proteins with thus far unknown functions could be involved. The biochemical analysis, especially the role of PIPs, and the Rab GTPases identified in the context of AP-1A and AP-3, provide indications about AP-1A and AP-3 function in vivo. The results could be interpreted in a way that AP-1A functions either in traffic from PI-4P positive membranes towards Rab11/Rab14 positive membranes or AP-1A coats assemble on PI-4P and Rab11 or Rab14 positive membranes, hence, TGN to endosomes traffic. The same holds true for AP-3, the results either suggest AP-3 mediates traffic from PI-3P positive towards Rab5/Rab7 positive membranes or they could be interpreted in a way that AP-3 assembles on PI-3P and Rab5 positive membranes for subsequent transport to Rab7 positive membranes, thus traffic from early to late endosomes. Overall, the results of this thesis research provided important insight into the formation of AP-1A and AP-3 coated structures and the potential interconnection between AP coats, actin nucleation and membrane fusion machineries. Alconada, A., U. Bauer, and B. Hoflack. 1996. A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network. Embo J. 15:6096-110. Bonifacino, J.S., and B.S. Glick. 2004. The mechanisms of vesicle budding and fusion. Cell. 116:153-66. Eskelinen, E.L., Y. Tanaka, and P. Saftig. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13:137-45. Ghosh, P., N.M. Dahms, and S. Kornfeld. 2003. Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol. 4:202-12. Matafora, V., S. Paris, S. Dariozzi, and I. de Curtis. 2001. Molecular mechanisms regulating the subcellular localization of p95-APP1 between the endosomal recycling compartment and sites of actin organization at the cell surface. J Cell Sci. 114:4509-20. Owen, D.J., B.M. Collins, and P.R. Evans. 2004. Adaptors for clathrin coats: structure and function. Annu Rev Cell Dev Biol. 20:153-91. Shin, H.W., N. Morinaga, M. Noda, and K. Nakayama. 2004. BIG2, a guanine nucleotide exchange factor for ADP-ribosylation factors: its localization to recycling endosomes and implication in the endosome integrity. Mol Biol Cell. 15:5283-94.

Vesicular traffic along the biosynthetic and endocytic pathways is essential for homeostasis of eukaryotic cells. However, it raised the question of how the proteins characteristic for each compartment are transported to their destination (Bonifacino and Glick, 2004). This study is especially focusing on the connection between the Golgi apparatus and the endosomal compartment, mediated by two parallel trafficking pathways regulated by the clathrin adaptors AP-1A and AP-3 (Owen et al., 2004). Typical cargo molecules sorted along the AP-1A regulated pathway are mannose 6-phosphate receptors (MPRs) (Ghosh et al., 2003) or the gpI envelop glycoprotein of the Vesicular Zoster virus (Alconada et al., 1996), while sorting of lysosomal membrane proteins like Lamp-1 and LimpII is AP-3 regulated (Eskelinen et al., 2003). To study how AP-1A and AP-3 coats are stabilized on membranes and to identify the protein networks involved, a liposome based in vitro assay that recapitulates the fidelity of protein sorting in vivo was developed and combined with proteomic screens. Therefore, liposomes carrying cytoplasmic domains of gpI or Lamp-1/LimpII were used as affinity matrix to recruit selectively AP-1A or AP-3 and associated protein machineries. The coated liposomes were then analyzed by mass spectrometry. Using the in vitro recruitment assay, it was possible to demonstrate that efficient and selective recruitment of AP-1A and AP-3 coats depends on the presence of several low affinity binding sites on membranes. Thus, AP-1A and AP-3 recognize their target membranes by activated Arf1 GTPases, organelle specific phosphoinositides, PI-4P and PI-3P respectively, and distinct cargo molecules carrying intact signals in their cytoplasmic domains. The implication of PI-3P in AP-3 recruitment was further supported by in vivo experiments. During the biochemical characterization of the assay, several lines of evidence indicated that cargo tails containing intact sorting signals stabilize not only AP-1A and AP-3 coats on membranes but also influence the membrane recruitment of Arf1. It is possible that cargo molecules indirectly drive an Arf1 amplification loop, thereby ensuring efficient AP coat assembly. The proteomic screens identified protein networks of ≈40 proteins selectively recruited on AP-1A coated structures. The most appealing result of the analysis was the presence of two additional protein machineries, one involved in actin nucleation the other involved membrane fusion. More precisely, the AP-1A analysis identified the selective recruitment of the AP-1A subunits and interacting molecules (clathrin, g-synergin), Arf1 and Arf1 effectors (Big2, Git1), Rac1 including Rac1 effectors (b-PIX, RhoGEF7) and a Rac1 dependent actin nucleation machinery (Wave/Scar complex, Arp2/3 complex, associated effectors) as well as members of a Rab machinery (Rab11, Rab14). This finding was further supported by in vivo colocalization studies of the AP-1A cargo CI-MPR with CYFIP2, a protein of the Wave/Scar complex, and the localization of Big2 and Git1 on Rab11 positive membranes (Matafora et al., 2001; Shin et al., 2004). The biochemical characterization revealed that the stabilization of AP-1A coats, most probably driven by cargo molecules that stabilize AP-1A and Arf1 on membranes, leads as well to the stabilization of the two other machineries. Thus, the results support the notion that cargo sorting, vesicular movement and membrane fusion are coordinated during early steps of vesicular traffic. In analogy, the proteomic screens on AP-3 coated structures identified as well ≈40 selectively recruited proteins, which constituted a similar supramolecular network of protein machineries involved in coat formation, action nucleation and membrane fusion via Rab proteins. Thus, beside the AP-3 coat including the AP-3 subunits, Arf1 and Arf effectors (Big1, ARAP1, AGAP1), members of the septin family involved in actin rearrangements and most of the already described effectors of Rab5 microdomains (EEA1, Rabaptin-5, Rabex-5, Vps45) involved in early endosomal dynamics were selectively recruited together with Rab5 and Rab7. Thus, the proteomic analysis of AP-1A and AP-3 coated structures suggest that both AP coats use similar principles - coats, actin nucleation devices and Rab fusion machineries - to assemble supramolecular structures needed for membrane traffic. Although we do not have the ultimate proves yet, it seems as AP-1A and AP-3 use different members of subcomplexes, hence different GTPase effectors, different actin nucleation machineries and different Rab GTPases, to regulate their specific transport pathways and to link the different protein machineries. The proteomic analysis revealed for example that they probably use different Arf and Rho GTPase effectors to link the coat with actin nucleation. However, this has to be proven experimentally. In order to understand the networks of protein interactions, bioinformatic tools were used as a first approach. Even though some clues about the overall organization of the supramolecular protein complexes were provided, the direct links to the Rab machinery are still elusive. Maybe the proteins with thus far unknown functions could be involved. The biochemical analysis, especially the role of PIPs, and the Rab GTPases identified in the context of AP-1A and AP-3, provide indications about AP-1A and AP-3 function in vivo. The results could be interpreted in a way that AP-1A functions either in traffic from PI-4P positive membranes towards Rab11/Rab14 positive membranes or AP-1A coats assemble on PI-4P and Rab11 or Rab14 positive membranes, hence, TGN to endosomes traffic. The same holds true for AP-3, the results either suggest AP-3 mediates traffic from PI-3P positive towards Rab5/Rab7 positive membranes or they could be interpreted in a way that AP-3 assembles on PI-3P and Rab5 positive membranes for subsequent transport to Rab7 positive membranes, thus traffic from early to late endosomes. Overall, the results of this thesis research provided important insight into the formation of AP-1A and AP-3 coated structures and the potential interconnection between AP coats, actin nucleation and membrane fusion machineries. Alconada, A., U. Bauer, and B. Hoflack. 1996. A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network. Embo J. 15:6096-110. Bonifacino, J.S., and B.S. Glick. 2004. The mechanisms of vesicle budding and fusion. Cell. 116:153-66. Eskelinen, E.L., Y. Tanaka, and P. Saftig. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13:137-45. Ghosh, P., N.M. Dahms, and S. Kornfeld. 2003. Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol. 4:202-12. Matafora, V., S. Paris, S. Dariozzi, and I. de Curtis. 2001. Molecular mechanisms regulating the subcellular localization of p95-APP1 between the endosomal recycling compartment and sites of actin organization at the cell surface. J Cell Sci. 114:4509-20. Owen, D.J., B.M. Collins, and P.R. Evans. 2004. Adaptors for clathrin coats: structure and function. Annu Rev Cell Dev Biol. 20:153-91. Shin, H.W., N. Morinaga, M. Noda, and K. Nakayama. 2004. BIG2, a guanine nucleotide exchange factor for ADP-ribosylation factors: its localization to recycling endosomes and implication in the endosome integrity. Mol Biol Cell. 15:5283-94.

No description available.